| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adherence to treatment with adalimumab, golimumab and ustekinumab in patients with inflammatory bowel disease
|
Calvo-Arbeloa, María
|
|
|
44 |
2 |
p. 62-67
|
artikel
|
| 2 |
Consensus to identify the dangerous drugs risks in hospital pharmacy services
|
Bernabeu-Martínez, María Ángeles
|
|
|
44 |
2 |
p. 51-61
|
artikel
|
| 3 |
Cost-minimization analysis of individually tailored or fixed-scheduled rituximab maintenance therapy for antineutrophil-cytoplasm antibody associated vasculitides
|
Guisado-Gil, Ana Belén
|
|
|
44 |
2 |
p. 46-50
|
artikel
|
| 4 |
Disease modifying therapies in multiple sclerosis: cost-effectiveness systematic review
|
Navarro, Cristian Eduardo
|
|
|
44 |
2 |
p. 68-76
|
artikel
|
| 5 |
Guillain-Barré syndrome of a patient under bortezomib treatment
|
Herráez-Albendea, María Mar
|
|
|
44 |
2 |
p. 77-78
|
artikel
|
| 6 |
Implementation of an anti-flu vaccination campaign in a hospital pharmacy service
|
Fernández-Cañabate, Eva
|
|
|
44 |
2 |
p. 41-45
|
artikel
|
| 7 |
La Sociedad Española de Farmacia Hospitalaria ante la especialidad única
|
Delgado-Sánchez, Olga
|
|
|
44 |
2 |
p. 39-40
|
artikel
|
| 8 |
Where we are, where we are going
|
Bermejo-Vicedo, Teresa
|
|
|
44 |
2 |
p. 37-38
|
artikel
|
Tijdschrift beschrijving